Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
AXGN Axogen Inc
- Stocks
- Healthcare
- NASDAQ: AXGN
Price (delayed)
$12.02
Market cap
$547.44M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$0.15
Enterprise value
$594.34M
Axogen (AXGN) is the leading company focused specifically on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. Axogen employees are passionate about helping to restore
Highlights
The company's EPS has surged by 70% YoY and by 35% QoQ
Axogen's net income has surged by 66% YoY and by 28% QoQ
Axogen's gross margin has decreased by 3.6% YoY and by 2.1% from the previous quarter
Key stats
What are the main financial stats of AXGN
Market
Valuations
Earnings
Shares outstanding
45.54M
Market cap
$547.44M
Enterprise value
$594.34M
Price to earnings (P/E)
N/A
Price to book (P/B)
5.06
Price to sales (P/S)
2.79
EV/EBIT
615.26
EV/EBITDA
67.63
EV/Sales
3.06
Revenue
$194.52M
Gross profit
$144.29M
Operating income
-$388,000
Net income
-$7.16M
EBIT
$966,000
EBITDA
$8.79M
Free cash flow
$1.19M
Per share
Balance sheet
Liquidity
EPS
-$0.15
EPS diluted
-$0.15
Free cash flow per share
$0.03
Book value per share
$2.38
Revenue per share
$4.3
TBVPS
$4.21
Total assets
$196.17M
Total liabilities
$90.8M
Debt
$71M
Equity
$105.37M
Working capital
$71.33M
Debt to equity
0.67
Current ratio
4.28
Quick ratio
2.5
Net debt/EBITDA
5.34
Margins
Efficiency
Dividend
EBITDA margin
4.5%
Gross margin
74.2%
Net margin
-3.7%
Operating margin
-0.2%
Return on assets
-3.7%
Return on equity
-7.1%
Return on invested capital
0.5%
Return on capital employed
0.6%
Return on sales
0.5%
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
AXGN stock price
How has the Axogen stock price performed over time
Intraday
1.09%
1 week
5.81%
1 month
23.28%
1 year
45.52%
YTD
-27.06%
QTD
10.78%
Financial performance
How have Axogen's revenue and profit performed over time
Revenue
$194.52M
Gross profit
$144.29M
Operating income
-$388,000
Net income
-$7.16M
Gross margin
74.2%
Net margin
-3.7%
AXGN's operating margin has soared by 98% YoY and by 89% QoQ
Axogen's operating income has soared by 98% YoY and by 88% from the previous quarter
The company's net margin has surged by 72% YoY and by 30% QoQ
Axogen's net income has surged by 66% YoY and by 28% QoQ
Price vs fundamentals
How does AXGN's price correlate with its fundamentals
Growth
What is Axogen's growth rate over time
Valuation
What is Axogen stock price valuation
P/E
N/A
P/B
5.06
P/S
2.79
EV/EBIT
615.26
EV/EBITDA
67.63
EV/Sales
3.06
The company's EPS has surged by 70% YoY and by 35% QoQ
AXGN's P/B is 17% below its last 4 quarters average of 6.1 but 5% above its 5-year quarterly average of 4.8
The equity has increased by 13% YoY
AXGN's P/S is 23% below its 5-year quarterly average of 3.6 and 18% below its last 4 quarters average of 3.4
The revenue has grown by 19% YoY and by 3.8% from the previous quarter
Efficiency
How efficient is Axogen business performance
Axogen's return on invested capital has surged by 163% QoQ and by 106% YoY
The company's return on sales has surged by 156% QoQ and by 105% YoY
Axogen's ROE has soared by 68% YoY and by 30% from the previous quarter
The ROA has soared by 67% YoY and by 29% from the previous quarter
Dividends
What is AXGN's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for AXGN.
Financial health
How did Axogen financials performed over time
The total assets is 116% higher than the total liabilities
AXGN's current ratio is up by 32% since the previous quarter and by 25% year-on-year
Axogen's quick ratio has increased by 20% from the previous quarter and by 20% YoY
The company's debt is 33% lower than its equity
The debt to equity has contracted by 13% YoY
The equity has increased by 13% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.